Anemia is a common and often underestimated complication of chronic kidney disease (CKD), contributing to increased morbidity and reduced quality of life. With recent advancements in anemia management, including novel therapeutic agents and updated clinical guidelines, there are now more effective strategies to optimize treatment outcomes.